ストックスクリーナーアプリを入手
259.12
1.10%
2.83
前日終値:
$256.29
開ける：
$255.66
24時間の取引高:
709.24K
Relative Volume:
0.68
時価総額：
$37.75B
収益：
$5.40B
当期純損益:
$1.49B
株価収益率:
25.61
EPS:
10.1168
ネットキャッシュフロー:
$1.78B
1週間 パフォーマンス:
+2.60%
1か月 パフォーマンス:
+2.34%
6か月 パフォーマンス:
-10.36%
1年 パフォーマンス:
+11.31%
1日の値動き範囲:
$254.28
$259.20
1週間の範囲:
$248.99
$262.17
52週間の値動き範囲:
$199.92
$293.81
Resmed Inc Stock (RMD) Company Profile
Compare RMD vs ISRG, BDX, MDLN, ALC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RMD
Resmed Inc
|
259.12 | 37.34B | 5.40B | 1.49B | 1.78B | 10.12 |
|
ISRG
Intuitive Surgical Inc
|
504.05 | 177.40B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
185.39 | 51.91B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
MDLN
Medline Inc
|
49.80 | 39.61B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
ALC
Alcon Inc
|
82.63 | 40.88B | 10.19B | 1.05B | 1.38B | 2.1044 |
Resmed Inc Stock (RMD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-16 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2025-09-18 | 開始されました | Citigroup | Buy |
| 2025-09-02 | アップグレード | CLSA | Hold → Outperform |
| 2025-07-15 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-03-19 | 開始されました | Morgan Stanley | Overweight |
| 2025-01-16 | 開始されました | Goldman | Buy |
| 2025-01-10 | 開始されました | Piper Sandler | Neutral |
| 2024-12-13 | 開始されました | Stifel | Hold |
| 2024-09-24 | 開始されました | Robert W. Baird | Outperform |
| 2024-09-18 | ダウングレード | Wolfe Research | Peer Perform → Underperform |
| 2024-09-04 | ダウングレード | Needham | Buy → Hold |
| 2024-06-25 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2024-06-24 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-02-06 | 再開されました | KeyBanc Capital Markets | Overweight |
| 2023-10-27 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-12 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-09 | アップグレード | JP Morgan | Neutral → Overweight |
| 2023-09-29 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2023-09-06 | アップグレード | Needham | Hold → Buy |
| 2023-09-05 | ダウングレード | UBS | Buy → Neutral |
| 2023-08-01 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-05-23 | 開始されました | UBS | Buy |
| 2023-04-14 | 開始されました | Mizuho | Buy |
| 2023-01-17 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-10-28 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-10-20 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-09-08 | アップグレード | Citigroup | Neutral → Buy |
| 2022-08-15 | ダウングレード | CLSA | Buy → Outperform |
| 2022-08-12 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-08-12 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-08-12 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-06-06 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-06 | 開始されました | Wolfe Research | Outperform |
| 2022-01-31 | アップグレード | Citigroup | Neutral → Buy |
| 2022-01-31 | アップグレード | Goldman | Neutral → Buy |
| 2022-01-28 | アップグレード | RBC Capital Mkts | Underperform → Sector Perform |
| 2022-01-24 | アップグレード | BofA Securities | Underperform → Neutral |
| 2022-01-24 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-01-13 | アップグレード | CLSA | Outperform → Buy |
| 2022-01-13 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2021-12-21 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-12-06 | アップグレード | Macquarie | Neutral → Outperform |
| 2021-10-22 | アップグレード | CLSA | Underperform → Outperform |
| 2021-08-02 | ダウングレード | CLSA | Outperform → Sell |
| 2021-08-02 | ダウングレード | Needham | Buy → Hold |
| 2021-07-28 | アップグレード | Jefferies | Underperform → Hold |
| 2021-07-26 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-07-14 | 開始されました | RBC Capital Mkts | Underperform |
| 2021-06-28 | ダウングレード | Citigroup | Buy → Neutral |
| 2021-06-22 | アップグレード | Macquarie | Neutral → Outperform |
| 2021-06-22 | 開始されました | Robert W. Baird | Neutral |
| 2021-06-21 | 繰り返されました | Needham | Buy |
| 2021-06-16 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2021-06-09 | アップグレード | CLSA | Sell → Outperform |
| 2021-05-21 | アップグレード | JP Morgan | Neutral → Overweight |
| 2021-05-11 | アップグレード | Citigroup | Neutral → Buy |
| 2021-04-30 | ダウングレード | Citigroup | Buy → Neutral |
| 2021-03-16 | アップグレード | Needham | Hold → Buy |
| 2020-11-02 | アップグレード | UBS | Neutral → Buy |
| 2020-10-30 | アップグレード | JP Morgan | Underweight → Neutral |
| 2020-10-27 | アップグレード | BofA Securities | Underperform → Neutral |
| 2020-08-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-06-17 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-01 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2020-05-01 | アップグレード | Oppenheimer | Perform → Outperform |
| 2020-02-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-02-03 | 開始されました | CLSA | Underperform |
| 2020-01-31 | ダウングレード | UBS | Buy → Neutral |
| 2020-01-10 | 開始されました | Oppenheimer | Perform |
| 2019-11-22 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2019-07-29 | アップグレード | UBS | Neutral → Buy |
| 2019-07-16 | ダウングレード | UBS | Buy → Neutral |
| 2019-05-06 | アップグレード | UBS | Neutral → Buy |
| 2019-04-18 | アップグレード | JP Morgan | Underweight → Neutral |
| 2019-01-25 | ダウングレード | Goldman | Buy → Neutral |
| 2019-01-25 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2018-10-26 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2018-07-02 | 開始されました | Goldman | Buy |
すべてを表示
Resmed Inc (RMD) 最新ニュース
Resmed Founder to Receive Prestigious Award - Sleep Review
NEOS Investment Management LLC Has $3.71 Million Stock Position in ResMed Inc. $RMD - MarketBeat
ResMed Inc. $RMD Shares Sold by BNP PARIBAS ASSET MANAGEMENT Holding S.A. - MarketBeat
Sleep Aids: Trends, Technologies and Global Markets to 2030 Featuring Key Players Fisher & Paykel Healthcare, ResMed, Philips, Alphabet, Apple and More - Yahoo Finance
Stock Recap: Is ResMed Inc stock showing strong momentumEarnings Recap Report & High Yield Equity Trading Tips - baoquankhu1.vn
ResMed Stock Outlook: Is Wall Street Bullish or Bearish? - Barchart.com
Skandinaviska Enskilda Banken AB publ Has $23.55 Million Stock Holdings in ResMed Inc. $RMD - MarketBeat
Vanguard Group Inc. Acquires 293,515 Shares of ResMed Inc. $RMD - MarketBeat
W.G. Shaheen & Associates DBA Whitney & Co Sells 4,003 Shares of ResMed Inc. $RMD - MarketBeat
Aug Action: How volatile is ResMed Inc stockJuly 2025 Big Picture & AI Powered Market Trend Analysis - baoquankhu1.vn
ResMed Inc. $RMD Shares Sold by ABN Amro Investment Solutions - MarketBeat
ResMed Inc. (RMD) Stock Analysis: Evaluating A 17.79% Potential Upside For Investors - DirectorsTalk Interviews
ResMed Inc Announces Changes in Beneficial Ownership - MSN
If EPS Growth Is Important To You, ResMed (NYSE:RMD) Presents An Opportunity - Yahoo Finance
Aberdeen Group plc Has $75.94 Million Stake in ResMed Inc. $RMD - MarketBeat
ResMed (RMD): Buy, Sell, or Hold Post Q4 Earnings? - Finviz
ResMed Inc. (RMD) Gains Analyst Confidence as Price Targets Rise on Strong Earnings - Insider Monkey
Why is the ResMed share price jumping 7% today? - MSN
Why analysts raise outlook for ResMed Inc. (RME) stockSwing Trade & Smart Money Movement Tracker - mfd.ru
7,172 Shares in ResMed Inc. $RMD Purchased by Caprock Group LLC - MarketBeat
Rhumbline Advisers Boosts Position in ResMed Inc. $RMD - MarketBeat
Envestnet Asset Management Inc. Raises Holdings in ResMed Inc. $RMD - MarketBeat
ResMed Inc. (NYSE:RMD) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
CPAP Headgear Market to See Thriving Worldwide | ResMed • Philips Respironics • Fisher & Paykel Healthcare - openPR.com
Dr Boreham’s Crucible: A rival may be circling, but ResMed isn’t losing any sleep - Stockhead
ResMed Tests Smart CPAP Pressure Tool in New Sleep Apnea Trial - TipRanks
ResMed (RMD) Valuation Check After Strong Earnings And Dividend Update - Yahoo Finance
Is It Time To Reassess ResMed (RMD) After Recent Medical Devices Sector Interest - Yahoo Finance
Resmed launches AirTouch F30i Comfort full-face fabric mask - MassDevice
Baader Bank Aktiengesellschaft Sells 8,794 Shares of ResMed Inc. $RMD - MarketBeat
Michael Farrell Sells 4,991 Shares of ResMed (NYSE:RMD) Stock - MarketBeat
Zacks.com featured highlights include Amphenol, GE Aerospace, ResMed and Ameriprise Financial - The Globe and Mail
ResMed CEO Farrell sells $1.36 million in stock By Investing.com - Investing.com Canada
ResMed Inc (RMD)'s Winning Formula: Financial Metrics and Compet - GuruFocus
ResMed’s Profitability Surge Driven by Operational Gains - AD HOC NEWS
With 73% ownership in ResMed Inc. (NYSE:RMD), institutional investors have a lot riding on the business - Yahoo Finance
ResMed General Counsel Sells Shares Under Pre-Set Trading Plan - TipRanks
ResMed Director Reports Changes in Stock Ownership - MSN
Why You Might Be Interested In ResMed Inc. (NYSE:RMD) For Its Upcoming Dividend - simplywall.st
ResMed (NYSE:RMD) Upgraded by Wall Street Zen to Buy Rating - MarketBeat
Insider Sell: Peter Farrell Sells 2,000 Shares of ResMed Inc (RM - GuruFocus
Insider Sell: Michael Rider Sells Shares of ResMed Inc (RMD) - GuruFocus
Resmed director Farrell sells $502k in stock By Investing.com - Investing.com Nigeria
Resmed: global general counsel Rider sells $13,000 in stock By Investing.com - Investing.com Australia
Resmed director Farrell sells $502k in stock - Investing.com
ResMed (NYSE:RMD) General Counsel Sells $13,000.00 in Stock - MarketBeat
ResMed (NYSE:RMD) Director Sells $502,620.00 in Stock - MarketBeat
Smart Sand, Inc. Achieves 140.93% Return, Outperforming NetApp and ResMed - Markets Mojo
RMD Stock Up Following Q2 Earnings & Revenue Beat, Margins Expand - TradingView
Resmed: global general counsel Rider sells $13,000 in stock - Investing.com
ResMed Chief Legal Officer Sells 50 Common Shares Of Firm - marketscreener.com
Resmed Inc (RMD) 財務データ
収益
当期純利益
現金流量
EPS
0.71%
4.62%
大文字化:
|
ボリューム (24 時間):